Digoxin and short term mortality after acute STEMI: Results from the MAGIC trial.

TitleDigoxin and short term mortality after acute STEMI: Results from the MAGIC trial.
Publication TypeJournal Article
Year of Publication2016
JournalInternational journal of cardiology
Volume218
Pagination176-180
Date Published2016 Sep 1
ISSN0167-5273
AbstractThe safety of digoxin has been a subject of debate for decades, most recently among patients with atrial fibrillation (AF). Digoxin has been used during the acute phase of ST elevation myocardial infarction (STEMI) complicated with AF or heart failure. Data about digoxin in this setting are scarce.
URLhttps://linkinghub.elsevier.com/retrieve/pii/S0167-5273(16)30926-3
DOI10.1016/j.ijcard.2016.05.022
PubMed Linkhttp://www.ncbi.nlm.nih.gov/pubmed/27236111?dopt=Abstract
Short TitleInt J Cardiol